ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Girard Sharp and Co-Lead Counsel Announce $235 Million Comprehensive Settlement with Altria in National JUUL E-Cigarette Predatory Advertising, Addiction and Injury Cases

Unprecedented in scope, speed, and significance, the global settlement, reached just after plaintiffs concluded their case in the bellwether trial in San Francisco, is the culmination of four years of a vast, unrelenting effort by plaintiffs and their counsel to hold Altria accountable for the 21st century’s ‘cigarettes redux’ youth nicotine plague.

Plaintiffs’ Co-Lead Counsel announce a comprehensive and historic $235 million settlement with Altria in the nationwide JUUL e-cigarette vaping predatory advertising, fraud, addiction and injury litigation currently facing bellwether trial in San Francisco. The settlement will resolve all remaining personal injury, consumer class action, and government entity cases brought in the national MDL and the JCCP in California against Altria (the earlier phase of the vast litigation ended in late 2022 when JUUL entered into four coordinated settlements with all plaintiff parties).

“This settlement represents a positive step forward in addressing the harmful impacts of vaping on the public,” said Girard Sharp partner Dena Sharp, Co-Lead Counsel for Plaintiffs in the litigation. “The settlement funds will compensate JUUL purchasers, young people, parents, and governmental organizations across America, and avoids the delay and uncertainty of continued court proceedings. We are proud of our clients and the federal court system that made this result possible. The legal system worked in this case, and we thank the jurors who devoted their time to this trial over the past few weeks.”

Together with the earlier settlements with JUUL in the federal multidistrict litigation captioned In re: Juul Labs, Inc., Marketing, Sales Practices and Products Liability Litigation, MDL No. 2913, and the coordinated proceeding captioned Juul Labs Product Cases, JCCP No. 5052, the settlements with Altria (nee Philip Morris) announced today will directly address youth use of e-cigarettes nationwide and provide compensation to JUUL purchasers.

The Altria settlement follows nearly four years of hard-fought litigation in both state and federal court. Co-Lead Counsel believe that resolving the litigation against Altria through settlement is categorically in the best interests of all plaintiffs. The settlement builds on Plaintiffs’ earlier successful efforts to hold JUUL itself accountable, and will provide monetary relief as well as continuing mandatory changes to Juul/Altria’s marketing and other practices, including prohibitions on youth marketing and the sale of flavors not authorized by the FDA.

The Altria settlement brings a final resolution to the personal injury, consumer class action, and government entity cases brought in the MDL and the JCCP brought on behalf of children, families, and JUUL purchasers everywhere in the U.S.

Next Steps

The Court will hold a hearing in the near future to review the proposed class settlement. If the settlement receives preliminary approval, a Class Settlement Administrator will be appointed to handle the process of making funds available to class members (including those that already filed claims as part of the JUUL settlement). At that time, the Class Settlement Administrator will notify class members about their rights under the Settlement. Concurrently, a claims process will begin for the Personal Injury and Government Entity settlements.

Girard Sharp Announces Historic $235M Comprehensive Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Case

Contacts

Dena Sharp

GIRARD SHARP LLP

601 California Street, Suite 1400

San Francisco, CA 94108

Telephone: (866) 981-4800

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.